Healthcare provider profile · identity verified

Bradley L Schroeder, DO

Internal Medicine · TOPEKA, KS · NPI 1467480285

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	573	150
Levothyroxine Sodium	Levothyroxine Sodium	524	148
Simvastatin	Simvastatin	350	97
Losartan Potassium	Losartan Potassium	335	96
Amlodipine Besylate	Amlodipine Besylate	334	105
Omeprazole	Omeprazole	282	81
Lisinopril	Lisinopril	232	69
Gabapentin	Gabapentin	220	60
Rosuvastatin Calcium	Rosuvastatin Calcium	181	60
Tamsulosin Hcl	Tamsulosin Hcl	165	47
Tramadol Hcl	Tramadol Hcl	164	33
Metformin Hcl Er	Metformin Hcl	163	47
Allopurinol	Allopurinol	149	37
Fluticasone Propionate	Fluticasone Propionate	147	44
Pioglitazone Hcl	Pioglitazone Hcl	142	41
Potassium Chloride	Potassium Chloride	126	38
Metformin Hcl	Metformin Hcl	124	35
Hydrochlorothiazide	Hydrochlorothiazide	117	34
Metoprolol Succinate	Metoprolol Succinate	112	28
Escitalopram Oxalate	Escitalopram Oxalate	111	32
Pantoprazole Sodium	Pantoprazole Sodium	109	33
Trazodone Hcl	Trazodone Hcl	93	25
Montelukast Sodium	Montelukast Sodium	92	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	89	19
Enalapril Maleate	Enalapril Maleate	80	26
Pravastatin Sodium	Pravastatin Sodium	80	25
Furosemide	Furosemide	77	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	13
Lovastatin	Lovastatin	72	19
Eliquis	Apixaban	69	17
Alprazolam	Alprazolam	68	16
Tizanidine Hcl	Tizanidine Hcl	66	17
Carvedilol	Carvedilol	64	18
Sertraline Hcl	Sertraline Hcl	60	20
Albuterol Sulfate Hfa	Albuterol Sulfate	59	22
Metoprolol Tartrate	Metoprolol Tartrate	59	18
Glipizide	Glipizide	58	14
Duloxetine Hcl	Duloxetine Hcl	55	13
Meloxicam	Meloxicam	55	18
Ezetimibe	Ezetimibe	52	17
Alendronate Sodium	Alendronate Sodium	49	19
Clopidogrel	Clopidogrel Bisulfate	49	16
Famotidine	Famotidine	49	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	11
Citalopram Hbr	Citalopram Hydrobromide	41	11
Telmisartan	Telmisartan	41	11
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Lorazepam	Lorazepam	37	suppressed
Memantine Hcl	Memantine Hcl	37	11
Celecoxib	Celecoxib	36	suppressed
Atenolol	Atenolol	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Glimepiride	Glimepiride	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	30
Finasteride	Finasteride	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Pregabalin	Pregabalin	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Spironolactone	Spironolactone	27	suppressed
Spiriva Handihaler	Tiotropium Bromide	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	12
Jardiance	Empagliflozin	22	suppressed
Prednisone	Prednisone	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	suppressed
Ondansetron Odt	Ondansetron	21	11
Terazosin Hcl	Terazosin Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Colestipol Hcl	Colestipol Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Temazepam	Temazepam	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Estradiol	Estradiol	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Linzess	Linaclotide	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Valsartan	Valsartan	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Ramipril	Ramipril	12	suppressed
Budesonide	Budesonide	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error